 Jacob Mark
Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endosonography | 4 | 2025 | 152 | 1.910 |
Why?
| | Pancreatic Cyst | 2 | 2024 | 60 | 1.530 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2024 | 227 | 1.400 |
Why?
| | Abdominal Pain | 2 | 2024 | 146 | 1.360 |
Why?
| | Foreign Bodies | 2 | 2023 | 104 | 1.320 |
Why?
| | Ultrasonography, Interventional | 3 | 2025 | 142 | 1.270 |
Why?
| | Pancreatitis, Chronic | 6 | 2024 | 53 | 1.220 |
Why?
| | Botulinum Toxins, Type A | 2 | 2025 | 51 | 1.080 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2024 | 211 | 1.010 |
Why?
| | Anal Canal | 2 | 2025 | 97 | 0.950 |
Why?
| | Pancreatitis | 3 | 2024 | 132 | 0.930 |
Why?
| | Constipation | 2 | 2025 | 94 | 0.920 |
Why?
| | Celiac Plexus | 1 | 2024 | 2 | 0.910 |
Why?
| | Neuromuscular Agents | 1 | 2025 | 39 | 0.910 |
Why?
| | Dyspepsia | 1 | 2024 | 10 | 0.910 |
Why?
| | Esophagus | 3 | 2024 | 255 | 0.900 |
Why?
| | Pancreas | 1 | 2024 | 328 | 0.760 |
Why?
| | Ketorolac | 1 | 2021 | 20 | 0.730 |
Why?
| | Esophageal Stenosis | 2 | 2019 | 54 | 0.730 |
Why?
| | von Hippel-Lindau Disease | 1 | 2020 | 12 | 0.690 |
Why?
| | Esophagoscopy | 2 | 2019 | 206 | 0.690 |
Why?
| | Duodenoscopes | 1 | 2020 | 7 | 0.660 |
Why?
| | Quarantine | 1 | 2020 | 29 | 0.650 |
Why?
| | Endoscopy | 2 | 2021 | 315 | 0.640 |
Why?
| | Esophageal Diseases | 1 | 2019 | 28 | 0.620 |
Why?
| | Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.610 |
Why?
| | Dilatation | 1 | 2019 | 65 | 0.600 |
Why?
| | Magnets | 1 | 2018 | 19 | 0.600 |
Why?
| | Catheterization | 1 | 2019 | 178 | 0.590 |
Why?
| | Bile Duct Diseases | 1 | 2018 | 14 | 0.580 |
Why?
| | Colonic Diseases | 1 | 2018 | 33 | 0.580 |
Why?
| | Self Expandable Metallic Stents | 1 | 2018 | 16 | 0.570 |
Why?
| | Intestine, Small | 1 | 2018 | 155 | 0.550 |
Why?
| | Child | 20 | 2025 | 21896 | 0.530 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 941 | 0.520 |
Why?
| | Colon | 1 | 2018 | 270 | 0.490 |
Why?
| | Eosinophilia | 1 | 2018 | 213 | 0.490 |
Why?
| | Patient Safety | 1 | 2018 | 305 | 0.460 |
Why?
| | Fellowships and Scholarships | 1 | 2018 | 302 | 0.460 |
Why?
| | Chronic Pain | 1 | 2018 | 271 | 0.440 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 476 | 0.430 |
Why?
| | Recurrence | 4 | 2024 | 1058 | 0.430 |
Why?
| | Adolescent | 12 | 2025 | 21402 | 0.350 |
Why?
| | Algorithms | 1 | 2018 | 1695 | 0.350 |
Why?
| | Clinical Competence | 1 | 2018 | 1086 | 0.350 |
Why?
| | Child, Preschool | 8 | 2025 | 11013 | 0.340 |
Why?
| | Postoperative Complications | 2 | 2019 | 2627 | 0.330 |
Why?
| | Pilot Projects | 2 | 2025 | 1684 | 0.320 |
Why?
| | Humans | 26 | 2025 | 136899 | 0.310 |
Why?
| | Retrospective Studies | 9 | 2025 | 15514 | 0.290 |
Why?
| | Exocrine Pancreatic Insufficiency | 1 | 2025 | 21 | 0.240 |
Why?
| | Female | 14 | 2025 | 72703 | 0.240 |
Why?
| | Prospective Studies | 3 | 2024 | 7543 | 0.240 |
Why?
| | Pyrrolidines | 1 | 2025 | 77 | 0.230 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 4 | 0.230 |
Why?
| | Male | 13 | 2025 | 67308 | 0.230 |
Why?
| | Injections | 1 | 2025 | 182 | 0.230 |
Why?
| | Hypertriglyceridemia | 1 | 2024 | 39 | 0.220 |
Why?
| | Trypsin Inhibitor, Kazal Pancreatic | 1 | 2024 | 6 | 0.220 |
Why?
| | Treatment Outcome | 5 | 2025 | 10768 | 0.220 |
Why?
| | Benzodioxoles | 1 | 2025 | 111 | 0.220 |
Why?
| | Patient Positioning | 1 | 2024 | 68 | 0.220 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2024 | 64 | 0.220 |
Why?
| | Diagnosis, Differential | 2 | 2018 | 1484 | 0.220 |
Why?
| | Quinolones | 1 | 2025 | 134 | 0.210 |
Why?
| | Deglutition | 1 | 2024 | 72 | 0.210 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 238 | 0.210 |
Why?
| | Nerve Block | 1 | 2024 | 76 | 0.210 |
Why?
| | Aminophenols | 1 | 2025 | 152 | 0.210 |
Why?
| | Gastrointestinal Diseases | 1 | 2025 | 208 | 0.200 |
Why?
| | Operative Time | 2 | 2024 | 142 | 0.200 |
Why?
| | Triglycerides | 1 | 2024 | 524 | 0.190 |
Why?
| | Indoles | 1 | 2025 | 411 | 0.190 |
Why?
| | Pancreatectomy | 1 | 2024 | 249 | 0.190 |
Why?
| | Pyrazoles | 1 | 2025 | 422 | 0.190 |
Why?
| | Pyridines | 1 | 2025 | 504 | 0.180 |
Why?
| | Botulinum Toxins | 1 | 2022 | 43 | 0.180 |
Why?
| | Pancreatic Ducts | 1 | 2021 | 81 | 0.180 |
Why?
| | Gastroenterology | 1 | 2023 | 181 | 0.170 |
Why?
| | Evidence-Based Medicine | 1 | 2024 | 744 | 0.170 |
Why?
| | Acute Disease | 4 | 2024 | 1000 | 0.170 |
Why?
| | Pediatrics | 2 | 2018 | 1119 | 0.160 |
Why?
| | Equipment Contamination | 1 | 2020 | 63 | 0.160 |
Why?
| | Adverse Outcome Pathways | 1 | 2018 | 4 | 0.150 |
Why?
| | Electrocoagulation | 1 | 2018 | 40 | 0.150 |
Why?
| | Disinfection | 1 | 2020 | 121 | 0.150 |
Why?
| | Quality of Life | 3 | 2025 | 2847 | 0.150 |
Why?
| | Operating Rooms | 1 | 2018 | 122 | 0.130 |
Why?
| | Disease Outbreaks | 1 | 2020 | 374 | 0.130 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1088 | 0.120 |
Why?
| | Eosinophilic Esophagitis | 1 | 2019 | 325 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2030 | 0.100 |
Why?
| | Patient Care Team | 1 | 2018 | 624 | 0.100 |
Why?
| | Cohort Studies | 2 | 2023 | 5711 | 0.090 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 133 | 0.090 |
Why?
| | Registries | 1 | 2019 | 2006 | 0.090 |
Why?
| | Risk Factors | 2 | 2023 | 10313 | 0.090 |
Why?
| | Infant | 3 | 2024 | 9408 | 0.080 |
Why?
| | Phenotype | 1 | 2018 | 3201 | 0.080 |
Why?
| | Risk Assessment | 1 | 2018 | 3432 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2019 | 6043 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2844 | 0.070 |
Why?
| | Young Adult | 2 | 2025 | 13157 | 0.060 |
Why?
| | United States | 2 | 2023 | 14595 | 0.060 |
Why?
| | Prone Position | 1 | 2024 | 30 | 0.060 |
Why?
| | Supine Position | 1 | 2024 | 39 | 0.060 |
Why?
| | Chloride Channel Agonists | 1 | 2025 | 80 | 0.060 |
Why?
| | Enzyme Replacement Therapy | 1 | 2024 | 16 | 0.060 |
Why?
| | Learning Curve | 1 | 2024 | 72 | 0.060 |
Why?
| | Drug Combinations | 1 | 2025 | 339 | 0.050 |
Why?
| | Quinolines | 1 | 2025 | 176 | 0.050 |
Why?
| | Anesthesia | 1 | 2024 | 190 | 0.050 |
Why?
| | Prevalence | 1 | 2025 | 2709 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2833 | 0.030 |
Why?
| | Receptors, Transferrin | 1 | 1995 | 24 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1773 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3282 | 0.030 |
Why?
| | Malaria | 1 | 1995 | 64 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2161 | 0.030 |
Why?
| | Iron | 1 | 1995 | 313 | 0.030 |
Why?
| | Mutation | 1 | 2024 | 3948 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5730 | 0.020 |
Why?
| | Adult | 2 | 2021 | 37595 | 0.010 |
Why?
| | Democratic Republic of the Congo | 1 | 1995 | 30 | 0.010 |
Why?
| | Ferritins | 1 | 1995 | 65 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1995 | 219 | 0.010 |
Why?
| | Solubility | 1 | 1995 | 248 | 0.010 |
Why?
| | Health Status Indicators | 1 | 1995 | 171 | 0.010 |
Why?
| | Hemoglobins | 1 | 1995 | 356 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1995 | 1324 | 0.010 |
Why?
| | Middle Aged | 1 | 1995 | 33118 | 0.000 |
Why?
|
|
Mark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|